Neuphoria Therapeutics extends shareholder rights plan expiration to October 27, 2027
Neuphoria Therapeutics entered into Amendment No. 1 to its shareholder Rights Agreement on October 23, 2026, extending the plan's Final Expiration Date to the close of business on October 27, 2027, unless earlier extended, modified or terminated. The filing reports this as a material modification to the rights of security holders, so shareholders should note that the plan now remains in effect for an additional period.
Key points
- Amendment No. 1 to the Rights Agreement dated October 23, 2026, between Neuphoria and Computershare Trust Company, N.A., as Rights Agent
- Final Expiration Date extended to the close of business on October 27, 2027, unless earlier extended, modified or terminated
- Original Rights Agreement dated October 27, 2025; the filing reports it as a material modification to security holder rights (Item 3.03)
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 23, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.